Dr. Chang’s clinical interests are related to general surgical oncology. He has expertise in the areas of breast cancer, melanoma, liver tumors and colorectal cancer. He is the interim director for the multidisciplinary Breast Care Center and director of the Gastrointestinal Oncology Program of the U of M Comprehensive Cancer Center.
Dr. Chang runs a laboratory program that has been continuously funded by the National Institutes of Health for more than 10 years. His research focuses on tumor immunology, immunotherapy, and gene therapy. He is Associate Director for Translational Research at the U of M Cancer Center and has expertise with clinical trials involving immunotherapy and gene therapy. He is co-Director of the Immunological Monitoring Core of the Cancer Center. In addition, he has trained many fellows in the laboratory and is Program Director for an NIH training grant entitled, “University of Michigan Surgical Oncology Research Training Program”. He is a member of numerous editorial boards and was a member of the NIH Study Section, Experimental Therapeutics 2. He is currently a member of the Subcommittee D–Clinical Trials study section.
Besides the administrative duties involving the U of M Cancer Center and the Division of Surgical Oncology, Dr. Chang has several roles in national organizations. He is a member of the Executive Council of the Society of Surgical Oncology. He is an American College of Surgeons Governor-at-large for the state of Michigan. He also is a member of the American College of Surgeons Commission of Cancer.